» Articles » PMID: 12034879

Basic FGF Mediates an Immediate Response of Articular Cartilage to Mechanical Injury

Overview
Specialty Science
Date 2002 May 30
PMID 12034879
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellularly regulated kinase (ERK), one of the three types of mitogen-activated kinases, was rapidly activated after cutting porcine articular cartilage either when maintained as explants or in situ. Cutting released a soluble ERK-activating factor from the cartilage, which was purified and identified by MS as basic fibroblast growth factor (bFGF). Experiments with neutralizing Abs to bFGF and an FGFR1 tyrosine kinase inhibitor showed that this growth factor was the major ERK-activating factor released after injury. Treating cartilage with the heparin-degrading enzyme heparitinase also caused release of bFGF, suggesting the presence of an extracellular store that is sequestered in the matrix and released upon damage. Basic FGF induced the synthesis of a number of chondrocyte proteins including matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinases-1, and glycoprotein 38, which were identified by MS. The strong induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 suggests that bFGF could have a role in remodeling damaged tissue.

Citing Articles

Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family.

Li H, Zhang J, Yuan D, Xie W, Ladel C, Mobasheri A Mil Med Res. 2024; 11(1):40.

PMID: 38902808 PMC: 11191355. DOI: 10.1186/s40779-024-00544-5.


Text Mining and Drug Discovery Analysis: A Comprehensive Approach to Investigate Diabetes-Induced Osteoporosis.

Wang C, Hu Y, Liang F Int J Med Sci. 2024; 21(3):464-473.

PMID: 38250601 PMC: 10797669. DOI: 10.7150/ijms.90829.


Analysis of proteins released from osteoarthritic cartilage by compressive loading.

Tsuno H, Tanaka N, Naito M, Ohashi S, Iwasawa M, Kadoguchi T Sci Rep. 2023; 13(1):18292.

PMID: 37880329 PMC: 10600228. DOI: 10.1038/s41598-023-45472-x.


Conditioned Medium - Is it an Undervalued Lab Waste with the Potential for Osteoarthritis Management?.

Rosochowicz M, Lach M, Richter M, Suchorska W, Trzeciak T Stem Cell Rev Rep. 2023; 19(5):1185-1213.

PMID: 36790694 PMC: 10366316. DOI: 10.1007/s12015-023-10517-1.


Fibroblast Growth Factors and Cellular Communication Network Factors: Intimate Interplay by the Founding Members in Cartilage.

Kubota S, Aoyama E, Takigawa M, Nishida T Int J Mol Sci. 2022; 23(15).

PMID: 35955724 PMC: 9369280. DOI: 10.3390/ijms23158592.


References
1.
Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E . Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol. 1999; 147(5):1109-22. PMC: 2169352. DOI: 10.1083/jcb.147.5.1109. View

2.
Yayon A, Klagsbrun M, Esko J, Leder P, Ornitz D . Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 1991; 64(4):841-8. DOI: 10.1016/0092-8674(91)90512-w. View

3.
Nugent M, Iozzo R . Fibroblast growth factor-2. Int J Biochem Cell Biol. 2000; 32(2):115-20. DOI: 10.1016/s1357-2725(99)00123-5. View

4.
Thiery J, Jouanneau J . Fibroblast growth factor-2. Int J Biochem Cell Biol. 2000; 32(3):263-7. DOI: 10.1016/s1357-2725(99)00133-8. View

5.
Skaper S, Kee W, Facci L, MacDonald G, Doherty P, Walsh F . The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects. J Neurochem. 2000; 75(4):1520-7. DOI: 10.1046/j.1471-4159.2000.0751520.x. View